Staphylococcus aureus isolated from atopic dermatitis skin produces staphylococcal enterotoxin Y that predominantly induces TCR Vα-specific expansion of T cells.
While investigating the virulence trait of Staphylococcus aureus adhering to skin of atopic dermatitis (AD) patients, we identified a novel ORF with structural similarity to superantigen from genome sequence data of an isolate from AD skin. Concurrently, the same ORF was identified in a bovine isolate of S. aureus and designated as SElY (H. K. Ono et al., Appl Environ Microbiol 81:7034-7040, 2015, https://doi.org/10.1128/AEM.01873-15). Recombinant SElYbov had superantigen activity in human peripheral blood mononuclear cells. They further demonstrated emetic activity in a primate animal model, proposed to rename SElY to SEY (H. K. Ono et al., pLoS Pathog 15 (5), 2019, doi.org/10.1371/journal.ppat.1007803). We herein investigated the prevalence of the sey gene in 270 human clinical isolates of various origins in Japan. Forty-two strains were positive for the sey, and the positive isolates were from skin diseases atopic dermatitis and impetigo/SSSS with detection rate of 17∼22%. There were three variants of SEY (SEY1, SEY2, and SEY3), and isolates producing SEY variants formed three distinct clusters corresponding to clonal complexes (CCs) 121, 59, and 20, respectively. Most sey + isolates produced SEY in broth culture. Unlike SEYbov, the three recombinant SEY variants exhibited stability to heat treatment. SEY predominantly activated human T cells with a particular TCR Vα profile, a unique observation since most staphylococcal enterotoxins exert their superantigenic activities through activating T cells with specific TCR Vβ profiles. SEY may act to induce localized inflammation via skin-resident T cell activation, facilitate pathogenesis of S. aureus infection in disrupted epithelial barriers.